De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Alkem Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Alkem Laboratories heeft een totaal eigen vermogen van ₹107.1B en een totale schuld van ₹14.2B, wat de schuld-eigenvermogensverhouding op 13.2% brengt. De totale activa en totale passiva bedragen respectievelijk ₹155.7B en ₹48.6B. De EBIT Alkem Laboratories is ₹21.8B waardoor de rentedekking -11.1 is. Het heeft contanten en kortetermijnbeleggingen van ₹42.7B.
Belangrijke informatie
13.2%
Verhouding schuld/eigen vermogen
₹14.18b
Schuld
Rente dekkingsratio | -11.1x |
Contant | ₹42.70b |
Aandelen | ₹107.14b |
Totaal verplichtingen | ₹48.61b |
Totaal activa | ₹155.75b |
Recente financiële gezondheidsupdates
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Recent updates
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You
Sep 24Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 27Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00
Jul 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Feb 08Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹104.1B ) ALKEM } overtreffen de korte termijn passiva ( ₹39.9B ).
Langlopende schulden: De kortetermijnactiva ALKEM ( ₹104.1B ) overtreffen de langetermijnschulden ( ₹8.7B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ALKEM heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van ALKEM is de afgelopen 5 jaar gedaald van 16.9% naar 13.2%.
Schuldendekking: De schuld van ALKEM wordt goed gedekt door de operationele kasstroom ( 137.3% ).
Rentedekking: ALKEM verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.